Malignant Lymphoma

Links shared publicly online about this topic

Revised Response Criteria for Malignant Lymphoma

jco.ascopubs.org — “Revised Response Criteria for Malignant LymphomaView full resource at jco.ascopubs.org

  • View Related
  • Share

Most Recently Shared on July 18, 2011 at 2:36 pm By:

Lymphomation Lymphomation.org Support

Revised Response Criteria for Malignant Lymphoma http://bit.ly/ruWNfW explains terms like CR, PR, Time to... http://fb.me/Cbeudpab

10 months ago...

Malignant Lymphoma: eMedicine Orthopedic Surgery

emedicine.medscape.com — “Overview: Primary lymphoma of bone is an uncommon disease and must be separated from skeletal involvement in systemic lymphoma. The former is stage IE (extranodal, see Staging) disease and may present to the orthopedic surgeon prior to biopsy ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 12, 2010 at 5:53 pm By:

MedscapeOrtho Medscape Orthopedics Health Site

Malignant Lymphoma: Improved survival in diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. http://bit.ly/8YSN5S

2 years ago...

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

news-medical.net — “Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 18, 2011 at 5:04 am By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas: Celge... http://bit.ly/jxvqPo

11 months ago...

Malignant lymphoma of the kidney mimicking rapid p... [Clin Nephrol. 2010] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on November 25, 2010 at 8:46 am By:

Lung_Breathing Lungs and Breathing OW Health

Malignant lymphoma of the kidney mimicking rapid progressive glomerulonephritis.: Authors: Weng SC, Shu KH, Wen ... http://bit.ly/hDH0a3

2 years ago...

The role of microRNA-150 as a tumor suppressor in malignant lymphoma. - F1000

f1000.com — “Lymphomagenesis, similar to tumorigenesis, has been related to a play between oncogenes and tumor suppressor genes. Specifically for extranodal natural killer (NK) cell lymphoma/leukemia, activation of the PI3K-AKT pathway emerged as an important factor for lymphomagenesis {1}. Previously, Dr Sawada's group discovered frequent overexpression of microRNA (miR)-21 and miR-155 that occurs in NK cell lymphoma by upregulating AKT signaling and downregulating tumor suppressive genes such as PTEN, PCD4View full resource at f1000.com

  • View Related
  • Share

Most Recently Shared on June 13, 2011 at 11:44 am By:

Spectrum Pharmaceuticals' ZEVALIN Was Highlighted During Oral Presentations and Abstracts at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland - Drugs.com MedNews

drugs.com — “Pivotal Debate on ZEVALIN vs. Rituximab in Maintenance Setting 6-1 2 Year FIT Study Follow Up Data Was Presented In Patients Who Achieved a Complete Response AfView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 20, 2011 at 12:16 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Spectrum Pharmaceuticals' ZEVALIN Was Highlighted During Oral Presentations and Abstracts at the 11th Inte... http://bit.ly/mJrf4v #drug

11 months ago...

Diphtheria Agent Targets Malignant Cells

medicalnewstoday.com — “Scott & White's Cancer Research Institute (CRI) is conducting a clinical trial that targets malignant T-cell lymphoma, a type of blood cancer.Lymphoma, which affects the white blood cellView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 17, 2010 at 1:04 pm By:

Lymphoma Basics - Lymphoma Center - EverydayHealth.com

everydayhealth.com — “There are two main types of lymphoma: Hodgkin disease and non-Hodgkin lymphoma. Learn the risk factors, symptoms of each at EverydayHealth.com.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on June 1, 2009 at 3:37 pm By:

EverydayHealth Everyday Health Health Site

Learn about lymphoma diagnosis, treatment and more in our new health center. #health #cancer http://bit.ly/Ijm5Q

3 years ago...

Oncology Article | Lymphoma

mdlinx.com — “High scatter T cells (THS): a reliable biomarker for malignant T cells in cutaneous T cell lymphomaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 30, 2010 at 9:26 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

High scatter T cells (THS): a reliable biomarker for malignant T cells in cutaneous T cell lymphoma: Blood http://bit.ly/gFjQy0 #oncology

1 year ago...

Oncology Article | Lymphoma

mdlinx.com — “Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 28, 2011 at 2:22 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis: Annals of Oncology http://bit.ly/f7Kski #oncology

1 year ago...

New Target For Possible Prevention Of A Rare Malignant Leukemia

medicalnewstoday.com — “New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.The study, led by investigators at The Ohio StateView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 2, 2011 at 12:05 pm By:

mnt_leukemia MNT Leukemia Health News

New Target For Possible Prevention Of A Rare Malignant Leukemia http://mnt.to/3RMn #lymphoma #leukemia

1 year ago...

Oncology Article | Lymphoma

mdlinx.com — “Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphomaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 8:39 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Correlational study of vascular endothelial growth factor expression and microvessel density in primar... http://bit.ly/jO1Ttb #oncology

11 months ago...

Gastroenterology Article | Lymphoma

mdlinx.com — “Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphomaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 3, 2011 at 10:59 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Correlational study of vascular endothelial growth factor expression and microvessel density in primary mali... http://bit.ly/mLz204 #GI

11 months ago...

Nice review article on the role of the p53 tumor suppressor in lymphoid malignancies such as #lymphoma and #myeloma: http://t.co/VHhKZIZl.

t.co — “Nice review article on the role of the p53 tumor suppressor in lymphoid malignancies such as #lymphoma and #myeloma: http://t.co/VHhKZIZl.View full resource at t.co

  • View Related
  • Share

Most Recently Shared on March 18, 2012 at 12:29 am By:

Myeloma_Doc Robert Z. Orlowski Physician, Doctor, and Internist

Nice review article on the role of the p53 tumor suppressor in lymphoid malignancies such as #lymphoma and #myeloma: http://t.co/VHhKZIZl.

2 months ago...

Second malignant neoplasm risk high for Hodgkin’s lymphoma, despite initial low-dose radiation | HemOncToday

hemonctoday.com — “Children with Hodgkin’s lymphoma remained at high risk for second malignant neoplasms, even when treated with low-dose radiation, accordView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 11, 2010 at 6:06 pm By:

HemOncToday HemOnc Today Oncology and Health News

Second malignant neoplasm risk high for Hodgkin’s lymphoma, despite initial low-dose radiation http://ow.ly/16oUs

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390